Filing Details
- Accession Number:
- 0001140361-17-015713
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-04-12 17:26:23
- Reporting Period:
- 2017-04-10
- Filing Date:
- 2017-04-12
- Accepted Time:
- 2017-04-12 17:26:23
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1228627 | Rexahn Pharmaceuticals Inc. | RNN | Pharmaceutical Preparations (2834) | 113516358 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1316420 | Ho Chang Ahn | C/O Rexahn Pharmaceuticals, Inc. 15245 Shady Grove Road, Suite 455 Rockville MD 20850 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-04-10 | 250,000 | $0.31 | 6,260,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-04-10 | 250,000 | $0.70 | 6,010,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to purchase) | Disposition | 2017-04-10 | 250,000 | $0.00 | 250,000 | $0.31 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2023-03-01 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 500,000 | Indirect | By spouse |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 17, 2016.
- The price of $0.7015 per share represents a weighted average. The shares were sold in multiple transactions at prices ranging from $0.70 to $0.709 per share, inclusive. The reporting person undertakes to provide upon request of the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
- The options vested and became exercisable based on the following schedule: 75,000 on March 1, 2014, 75,000 on March 1, 2015 and 100,000 on March 1, 2016.
Billionaire Hedge Funds
